Last updated on May 2019

A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease


Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of the study drug Mirikizumab in participants with active Crohn's Disease.

Clinical Study Identifier: NCT02891226

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.